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Early innate events that enable priming of antifungal
CD4 T cells are poorly understood. We engineered
an attenuated fungal vaccine with a model epitope,
EaRFP, to track vaccine immunity to Blastomyces
dermatitidis during yeast recognition, antigen pre-
sentation, and priming of naive T cells. After subcuta-
neous injection of the vaccine, monocyte-derived
inflammatory dendritic cells (DCs) are the earliest
and largest population that associates with yeast,
carrying them into the draining lymph nodes. Despite
marked association with yeast, these DCs fail to
display surface peptide:MHC complexes or prime
naive T cells. Instead, the ability to display antigen
and prime CD4 T cells resides with lymph node-resi-
dent DCs after antigen transfer from immigrant DCs
and with skin migratory DCs. Our work reveals the
dynamic interplay among distinct DC subsets that
prime naive CD4 T cells after yeast are injected in
the skin and discloses the cellular elements under-
lying vaccine-induced immunity to fungi.
INTRODUCTION
An increase in fungal diseases has fueled scientific interest in
fungal pathogenesis and antifungal immunity, but a vaccine for
any of the human systemic mycoses has never been developed.
We genetically engineered an attenuated vaccine against exper-
imental infection with the dimorphic fungus Blastomyces derma-
titidis, the agent of blastomycosis. Inhalation of spores into the
lung of a mammalian host promotes a phase transition to the
pathogenic yeast form (Bradsher, 1988), which produces pneu-
monia or disseminated infection, depending on the host’s
immune status. In a murine model, intratracheal administration
of spores or yeast leads to pneumonia with 100% mortality.
Subcutaneous (s.c.) administration of the attenuated vaccine
protects mice against experimental infection and induces steril-
izing immunity (Wu¨thrich et al., 2000).474 Cell Host & Microbe 7, 474–487, June 17, 2010 ª2010 Elsevier InThe development of fungal vaccines requires an under-
standing of the elements that bridge innate and adaptive
responses during the generation of antifungal immunity. CD4+
T cells mediate the control and clearance of fungi, with Th1
responses having a requisite role, including in vaccine immunity
(Romani, 2008). During the earliest stages of fungal infection,
pattern recognition receptors expressed on cells of the myeloid
lineage enable the host to first sense the presence of pathogenic
fungi and fungal surfaces (Brown, 2006; Netea et al., 2008).
Myeloid cells, particularly dendritic cells (DCs), bridge innate
and adaptive immune response to pathogens across all king-
doms. Because of this, DCs have become a target for novel
vaccine development strategies (Steinman, 2008).
DCs are a heterogeneous population of antigen (Ag)-present-
ing cells (APCs) that drive immune responses toward inflamma-
tory or regulatory pathways (Banchereau and Steinman, 1998).
Adaptive immunity is regulated and fine-tuned by DCs, depend-
ing on the type of Ag and DC subset residing at the site of
pathogen entry (Dudziak et al., 2007). In the skin-draining lymph
nodes (LNs), which represent the chief site of T cell priming after
s.c. vaccination, there are two major categories of DCs: migra-
tory DCs and LN-resident DCs (Villadangos and Schnorrer,
2007). Migratory DCs include skin-resident DCs and mono-
cyte-derived inflammatory DCs. Skin DCs are comprised of
subsets of dermal DCs (CD103+ and CD103) and Langerhans
cells (Kaplan et al., 2008), whereas monocyte-derived DCs arise
when circulating monocytes differentiate into DCs at the site of
inflammation (Leo´n et al., 2007).
The roles served by these distinct subsets of DCs in priming
T cell responses have been analyzed in response to soluble
model Ags, viruses, bacteria, and parasites, but they are less
well understood for the fungi. In Leishmania major cutaneous
infection models and in systems using model soluble proteins
such as EaRFP injected s.c., skin DCs are key players in control-
ling infection or inducing T cell responses (Itano et al., 2003; Moll
et al., 1993). Skin DCs also regulate hypersensitivity responses
(Kaplan et al., 2005) by taking up foreign or self-proteins at the
site of infection, carrying the cargo to the draining LN, and pre-
senting the Ags to T cells (Heath et al., 2004). Skin migratory
DCs also may cooperate with LN-resident DCs to induce T cell
responses by transferring viral Ag to resident DCs (Allan et al.,
2006) and, in response to ovalbumin (OVA), allowing residentc.
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migratory DCs induce proliferation (Allan et al., 2006). Hence,
LN-resident DCs also contribute to presenting Ag in the skin-
draining LNs (Iezzi et al., 2006; Lee et al., 2009).
Monocyte-derived DCs have gained interest in priming T cell
responses to microbes (Hohl et al., 2009; Serbina et al., 2008).
Monocyte-derived inflammatory DCs were shown to prime Th1
responses in a model of cutaneous Leishmaniasis (Leo´n et al.,
2007) and to prime Ag-specific CD4+ Tg cells in an experimental
model of pulmonary aspergillosis (Hohl et al., 2009). In Asper-
gillus infection, CCR2+ Ly6Chi monocyte-derived DCs were
necessary for priming T cells in the lung, but not in the spleen,
underscoring the differences in how T cells are primed in
different tissue compartments. The studies above clarify how
distinct DC subsets prime T cells in response to model or non-
fungal agents or to fungi that are inhaled into the lung during
primary infection. They do not offer insight into the early cellular
dynamics that underpin generation of a vaccine-induced
immune response to fungi, especially initiated in the skin.
We engineered vaccine yeast to express the model Ag EaRFP
(Rudensky et al., 1991) to assess sequential stages during the
induction of vaccine immunity to fungi after s.c injection. We
show that monocyte-derived inflammatory DCs initially take up
the majority of vaccine yeast and traffic them to the draining
LNs. A subsequent, smaller wave of vaccine-Ag trafficking to
the LN is mediated by skin-derived DCs. Despite a large associ-
ation of yeast with monocyte-derived DCs, the direct priming of
naive Ag-specific CD4 T cells in vivo is governed by LN-resident
DCs and skin-derived DCs, whereas monocyte-derived DCs
function mainly as carriers of Ag particles to the draining LN.
RESULTS
DC Subsets that Associate with Vaccine Yeast
in the Draining LNs
We tracked, analyzed, and characterized the cells that associate
with attenuated vaccine yeast in the skin-draining LNs by stain-
ing the yeast with the fluorescent cell linker PKH26. Thus, the
cells that associate with vaccine yeast in the draining LNs are
PKH26+. To elucidate the kinetics of yeast or yeast-Ag delivery
into the draining LNs, mice were vaccinated s.c., and the drain-
ing LNs were harvested at serial time points. PKH26+ cells
entered the LNs at 24 hr and peaked 2–3 days later (Figure 1).
Itano et al. (Itano et al., 2003) found that soluble protein injected
s.c. entered the draining nodes 30 min later. This rapid entry was
due to non-cell-associated delivery of the Ag via the lymphatics.
In contrast, yeast PKH26 signal in the node was delayed until
24 hr after vaccination, suggesting that yeast ‘‘particles’’ are
actively transported by migratory cells rather than by passive
movement of soluble fungal Ag into the draining node (Figure 1).
Since DCs prime naive T cells in the draining LNs, we sought to
characterize the DCs that harbor and present yeast Ag(s) at this
site. Multiple subsets of DCs have been defined by differences in
the expression of surface markers (Lo´pez-Bravo and Ardavı´n,
2008; Villadangos and Schnorrer, 2007). We used CD11c/
CD11b to identify five potential populations of DCs that contain
yeast (Figure 1B). By FACS analysis, we found a strong correla-
tion between CD11b+ APC populations and PKH26. More than
90% of PKH26+ cells are CD11b+, and none is present in theCell HCD11c single-positive population (Figure 1B). We created gates
among the populations of PKH+ cells that correspond to estab-
lished populations of DCs (Lo´pez-Bravo and Ardavı´n, 2008). We
used additional markers (Figure 1C) to confirm and further char-
acterize the identities of the five populations of yeast-loaded
cells near the peak of influx into the LN (day 3). Population I
corresponds to conventional LN-resident DCs, which express
high levels of CD11c and MHC class II (MHCII) and include
both CD8+ and CD8 subsets (Villadangos and Schnorrer,
2007). We used skin-FITC painting, which tracks migratory skin
DC populations, to establish that population I is FITC and
confirm that this is the LN-resident DC population (Figure S1).
In contrast, populations IV and V are migratory skin DCs. Skin
DCs are a heterogeneous population of several subsets of
dermal DCs and Langerhans cells, identifiable with DEC205
and Langerin markers (Segura and Villadangos, 2009). About
20% of cells in populations IV and V displayed these markers
(Figure 1C). These cells also were FITC+ after skin painting
(Figure S1), supporting their identity as migratory skin DCs (Allan
et al., 2006; Iezzi et al., 2006). We used two alternate means of
tracking yeast associated with DCs to verify the findings with
PKH26: (1) vaccine yeast engineered with red fluorescent protein
and (2) the cell-permeable dye CFSE. Each method yielded
results qualitatively similar to those with PKH26, notably in the
distribution of yeast among DC subsets (Figure S2). Due to the
sensitivity and stability of PKH26, we used it for the rest of our
experiments.
Monocyte-derived inflammatory DCs are blood monocytes
that differentiate into DCs upon inflammation. They express
a monocyte Ly6C marker and exhibit a DC-like CD11cint/+
phenotype (Leo´n et al., 2007; Nakano et al., 2009). Populations
II and III are Ly6C+ and >90%CD11bhi, indicating they aremono-
cyte-derived cells (Figure 1C). Population II also expresses
CD11c, indicating they are likely monocyte-derived DCs. In
contrast, population III expresses low or no CD11c and is thus
likely to be infiltrating monocytes or macrophages. Overall, our
phenotypic analysis showed that yeast associated with three
major populations of DCs in the draining LNs of vaccinated
mice: LN-resident DCs (population I), monocyte-derived DCs
(population II), and skin-derived DCs (populations IV and V).
TheKinetics andDynamics of Vaccine Yeast-Associated
Cell Populations in the Draining LNs
To investigate the kinetics and dynamics of DC subset trafficking
of vaccine yeast into the draining LNs, we analyzed the distribu-
tion of PKH26+ cells serially over 7 days. Monocyte-derived DCs
are the first population to enter the LN with PKH26+ yeast. They
appear as a dense population at 24 hr by FACS, when they
account for 47% of the cells associated with vaccine yeast
(Figure 2A). These inflammatory DCs represent the single largest
population of cells associated with yeast in the nodes, both in
terms of the distribution of PKH26+ yeast among DCs and the
numbers of cells with yeast in the node (Figures 2A and 2B).
Skin DC subsets (IV and V) with vaccine yeast appear in the
node 1 day after monocyte-derived DCs (Figure 2B) and account
for25%of cells associated with vaccine yeast by 48–72 hr after
vaccination (Figure 2A). During the first 72 hr after vaccination,
PKH26+ yeast steadily associate with resident, conventional
DCs (Figure 2B). Since this population (I) is not migratory, theost & Microbe 7, 474–487, June 17, 2010 ª2010 Elsevier Inc. 475
Figure 1. Appearance of Yeast in the Skin-Draining LNs of Vaccinated Mice
(A) Mice were vaccinated once s.c. with 107 PKH26+ yeast. LNs were collected from 6 hr to 8 days after vaccination and analyzed for cells containing PKH26+
yeast. Cells were gated on forward scatter/side scatter (FSC/SSC), followed by a live-cell gate based upon violet fixable live/dead stain.
(B) Five populations of APCs with PKH26+ yeast were identified based on CD11c/CD11b expression in LN cells 72 hr after vaccination (third panel). The distri-
bution of PKH26+ yeast among cells is indicated by the percent of PKH26+ cells in each gate. The fraction of LN cells in each gate is shown in vaccinated mice
(second panel) and unvaccinated controls (first panel). In the far right panel, PKH26+ cells (red) were superimposed on total LN cells (blue) to depict the frequency
of Ag+ cells in each gate at the peak of influx 72 hr after vaccination.
(C) Identity of LN cells with PKH26+ yeast. Name and Roman numeral in the right margin correspond to gates in (B). The red and blue populations of LN cells were
analyzed separately. The red histogram shows the phenotype of PKH26+ cells in the respective subset in (B) for vaccinated mice; the blue one shows the pheno-
type of the respective subset under noninflammatory conditions (unvaccinated mice). Results in (A)–(C) are representative of five independent experiments.
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migratory cells may transfer vaccine Ag to resident cells within
the draining LN. Monocytes or macrophages (population III)
increased slowly during vaccination but accounted for only
a small number of yeast-associated cells in the LN. A PKH26+
CD11c CD11b population also accumulated in the LN over
time. This population is debris from dying PKH26+ cells because
of its small size on the forward/side-scatter analysis and lack of
staining for cellular markers (data not shown). Neutrophils made
up a small percentage of CD11b+ cells in the LN, but few vaccine
yeast were associated with these cells (Figure S3). Thus, the
chief cell populations that associated with vaccine yeast in the
draining LNs are monocyte-derived inflammatory DCs, skin-
derived DCs, and resident conventional DCs. The temporal476 Cell Host & Microbe 7, 474–487, June 17, 2010 ª2010 Elsevier Inappearance of yeast with monocyte- and skin-derived DCs
before they associate with resident DCs is consistent with the
possibility that vaccine Ag is transferred to resident DCs in
the LN. At the 72 hr peak of PKH26+ cell influx, the number
of yeast-associated APCs is distributed evenly among three or
four populations, suggesting that multiple DC subsets partici-
pate in the vaccine-induced protective immune response to
fungi.
We considered that the distribution of live vaccine yeast
among DC subsets could be affected by replicating yeast in
the LN. We cultured the LNs of mice 72 hr after vaccination,
but found <10 yeast/animal (limit of detection). We also
compared the distribution of vaccine yeast among DCs in the
LN after vaccination with live or heat-killed yeast, and it wasc.
Figure 2. The Dynamic Distribution of Yeast Ag-Loaded Cells in the Draining LNs
(A) Mice were analyzed serially for 7 days after vaccination. LN cells with PKH26+ yeast (red) were analyzed and gated according to expression of CD11c and
CD11b. Gates and Roman numerals (A) correspond to those in Figure 1. The changing distribution of PKH26+ yeast and percent of PKH26+ cells in each gate and
population are depicted over time.
(B) The distribution of PKH26+ yeast among the LN cell populations is shown in absolute numbers at each time point. Data are the mean ±SD of two independent
experiments, each with four mice per time point or group. *p < 0.05 denotes the subset increased significantly at that time point versus the preceding one.
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yeast into the LN, not replication in the node. We also evaluated
whether the appearance of yeast Ag within LN-resident cells
required ongoing delivery of yeast after vaccination. Pertussis
toxin administered together with the vaccine to block cell migra-
tion halted entry of yeast into the LN (Figure S5). In contrast,
when toxin was given 24 hr after vaccination, yeast still appeared
in all of the DC subsets, including LN-resident DCs at 72 hr.
These results suggest that cells from the vaccine site deliver
yeast into the node and may transfer them to LN-resident DCs.
Alterations of Vaccine Delivery into the LNs of CCR2/,
CCR7/, and CD11cDTR Mice
We concluded above that monocyte-derived DCs and skin-
derived DCs are potential migratory populations that ferry
vaccine yeast into the LN for possible Ag transfer to resident
conventional DCs (Figure 1B). We used the chemokine system
to restrict the migration of DC subsets into the LN and analyze
the impact on distribution and number of PKH26+ cells in the
LNs of vaccinated mice. Chemokine receptor 2 (CCR2) governs
the migration of Ly6C+ monocytes (Serbina et al., 2008), andCell Hchemokine receptor 7 (CCR7) the migration of skin-derived
DCs (Ohl et al., 2004). Vaccination of CCR2/ and CCR7/
mice sharply altered the distribution and number of PKH26+ cells
in the draining LNs. In CCR2/ mice, monocyte-derived DCs
and monocytes (populations II and III) were greatly diminished,
shifting PKH26+ cells to skin DCs (IV and V) (Figures 3A and
3B). In CCR7/ mice, skin-derived dermal and Langerhans
DCs were reduced, shifting PKH26+ cells to the monocyte pop-
ulations. The total number of PKH26+ cells in the draining LNs of
vaccinated mice was also reduced—by about 2- to 4-fold—in
the absence of CCR2 or CCR7 (Figure 3C). The CCR2/ mice
show the largest reduction of PKH26+ cells in the draining LNs,
underscoring their prominent role in trafficking vaccine yeast
(Figure 2).
Our findings in CCR2/ and CCR7/ mice support the view
that migratory, monocyte-derived DCs and skin DCs (popula-
tions II, III, IV, and V) ferry vaccine yeast into the nodes of vacci-
nated mice. To address the contribution of LN-resident DCs
(population I), which are CD11chi, we used CD11cDTR mice,
conditionally depleting CD11chi cells by injection of diphtheria
toxin (Probst et al., 2005). In vaccinated mice, depletion ofost & Microbe 7, 474–487, June 17, 2010 ª2010 Elsevier Inc. 477
Figure 3. Delivery of Vaccine Yeast into the LNs of CCR2/, CCR7/, and CD11cDTR Mice
(A and B) Wild-type or CCR2/, CCR7/, and CD11cDTRmice were vaccinated with 107 PKH26+ yeast, and the draining LNswere harvested 3 days later at the
peak of cell influx to analyze the presence and distribution of PKH26+ yeast in LN cells. CD11cDTR mice were depleted of LN-resident DCs as in Experimental
Procedures. The percent (A) and absolute number (B) of PKH26+ yeast-bearing cells are shown for the gated populations of DCs described in Figures 1 and 2.
Arrows indicate missing cell populations. *p < 0.05 versus wild-type mice, except for monocytes in CCR7/ mice.
(C) The total number of PKH26+ cells in the LNs of vaccinated mice. Error bars represent the mean ±SD of four mice/group. Data are representative of three inde-
pendent experiments. *p < 0.05 versus wild-type mice.
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(Figures 3A and 3B), but did not significantly alter the total
number of PKH26+ cells in the draining LNs (Figure 3C). Thus,
eliminating CD11chi cells did not blunt the delivery of yeast into
the LNs, but instead redistributed yeast Agwithin the node, again
suggesting that vaccine Ag might be transferred within the node
from migratory DCs to resident DCs (Allan et al., 2006).478 Cell Host & Microbe 7, 474–487, June 17, 2010 ª2010 Elsevier InDC Subsets that Process and Display Vaccine Yeast Ag
in the Draining LNs
We observed that skin-derived DCs, monocyte-derived DCs,
and LN-resident DCs contain vaccine yeast by PKH26+ stain-
ing, but the Ag-processing capability of these cells was not
addressed. We used YAe antibody to detect Ea peptide dis-
played by MHCII (Itano et al., 2003), in conjunction with vaccinec.
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APCs that display yeast-derived Ag. Since T cell epitopes of B.
dermatitidis are unknown, Ea serves as a derivative of the yeast
surface protein BAD1 to let usmonitor yeast-Ag display by APCs
(see Experimental Procedures). To validate this Ag detection
system, we conducted in vitro studies with bonemarrow-derived
DCs (BMDCs). BMDCs cocultured with products containing Ea
sequence (Ea peptide, soluble EaRFP, and EamCherry yeast)
showed a distinct YAe+ population (Figure 4A). Nearly 20% of
the cells stained positive for Ea:MHCII complexes after coculture
from 1 to 4 days with EamCherry yeast. In contrast, cells cocul-
tured with an irrelevant peptide (SIINFEKL), protein (OVA), or
yeast lacking Ea (TR20 control) showed low background staining
with the YAe antibody (Figure 4A).
To track cells that display vaccine yeast Ea-Ag in vivo, we
immunizedmice with EamCherry yeast or controls of TR20 yeast
(negative) or soluble EaRFP (positive). The CD11b+ population of
LN cells showed an increase in YAe+ staining in mice that got
EaRFP or EamCherry yeast, as compared to naive mice and
TR20 vaccine controls (Figure 4B). CD11b+ cells from the Eam-
Cherry yeast group had 2-fold more YAe+ cells than the TR20
group (Figure 4B), and gating on the CD11b+ PKH26+ LN cells
accentuated the difference between these two groups (Fig-
ure 4C). We also noted a constant population of YAe+ CD11b
cells in all of our samples, consistent with Ea expression as
a self-Ag (Murphy et al., 1992). Self-Ag display did not interfere
with our identification of DCs that display yeast Ag, since
PKH26+ cells are CD11b+ rather than CD11b (Figure 1B).
Thus, YAe staining, together with gating on PKH26 and CD11b,
enabled us to discriminate the display of yeast Ea from self-Ag.
To identify the APCs that process and display yeast-derived
Ea in relation to the Ag-loaded cells, we overlaid the LN popula-
tions of YAe+ cells and PKH26+ cells for mice that were vacci-
nated with EaRFP, TR20 yeast, or EamCherry yeast. In the
EaRFP (soluble protein)-vaccinated animals, the majority of
YAe+ cells reside within the skin-derived DC populations IV
and V (Figure 4D), similar to what has been reported (Itano
et al., 2003). In contrast, the most abundant display of Ea:MHCII
in EamCherry yeast-vaccinated animals occurs within the LN-
resident conventional DCs, with surprisingly few YAe+ cells in
the monocyte-derived DC and monocyte/macrophage gates
(Figure 4D). This finding implies that monocyte-derived cells
carry yeast into the LN, but may play a limited role in directly dis-
playing yeast Ag to naive T cells. Because Ea:MHCII display is
necessary but not sufficient for Ag presentation to naive
T cells, we sought to identify the DCs capable of both displaying
yeast Ag and priming naive Ag-specific T cells in the LN.
Naive TEa T Cells Report Fungal Ag Processing
and Presentation in the Draining LNs
Using naive TEa Tg T cells specific for Ea:MHCII complexes
(Murphy et al., 1992; Rudensky et al., 1991), we determined
how the display of fungal Ea-Ag in the draining nodes, as
detected by the YAe antibody, correlates with the priming of
naive T cells. We found above that CD11b+ cells in the LN asso-
ciate with vaccine yeast (Figure 1B) and display yeast-derived
Ea-Ag (Figure 4B). We therefore collected CD11b+ cells from
mice vaccinated with soluble EaRFP, EamCherry yeast, or TR20
control yeast and cocultured them ex vivo with TEa cells to seeCell Hif Ag display activated the naive T cells. CD11b+ cells from the
soluble EaRFP and EamCherry yeast groups were able to acti-
vate the TEa cells, as observed by increased surface expression
of CD25, CD44, and CD69 and decreased expression of CD62L
(Figure 5A); CD11b+ cells from naivemice and TR20 controls and
CD11b cells from any vaccine group failed to activate the TEa
cells (Figure 5A and data not shown).
To see if vaccine Ea display in the LN primed naive TEa cells
in vivo, we adoptively transferred TEa cells into mice and vacci-
nated them with EamCherry or TR20 control yeast (Figure 5B).
Three days after vaccination, TEa cells in the EamCherry-vacci-
nated animals were primed, as noted by their CFSElo and CD44hi
and CD69hi activated phenotype (Figure 5B). In the TR20 group,
in contrast, TEa cells failed to become activated and retained the
naive phenotype of CFSEhi, CD44lo, and CD69lo. Thus, although
staining of draining LNs with antibody showed only a small
increase in the YAe+ population in mice vaccinated with Eam-
Cherry yeast versus TR20 yeast (Figure 4C), the population is
biologically active in priming naive Ag-specific T cells. Ea dis-
played as a self-Ag in the CD11b population in the LN (Figures
4B and 4C) did not interfere with the specificity of TEa cells for
vaccine yeast-derived Ea-Ag, since naive TEa cells failed to
become activated in either unvaccinated mice or those that
received TR20 control yeast (Figure 5B). Naive TEa cells
expanded 5- to 8-fold more in mice vaccinated with EamCherry
compared to these control groups (Figure 5C).
Soluble Ag administered s.c. enters the LN in two waves, at
30 min and again at 14 hr, with corresponding early T cell
priming (Itano et al., 2003). We observed that vaccine yeast are
dynamically distributed among APC populations in the draining
LNs of mice over 7 days after vaccine administration. Here, we
analyzed how the kinetics of vaccine Ag delivery into the draining
nodes correlates with the kinetics of priming naive T cells at this
site. After adoptive transfer of TEa cells, their activation and
proliferation was monitored for 12 days in response to vaccina-
tion with EamCherry or control yeast. TEa cells initially prolifer-
ated at 72 hr in response to EamCherry yeast, as measured
by their loss of CFSE (Figure 5D). Analysis of other T cell activa-
tion markers, such as surface CD25, CD44, or CD69, showed
evidence of TEa activation about 24–36 hr earlier (data not
shown). Thus, priming of naive T cells by vaccine yeast corre-
lates closely with the initial appearance of PKH26+ signal in the
draining LNs of vaccinated mice (Figure 1). The lack of evidence
of T cell priming before 32 hr in response to vaccine yeast
supports the idea that fungal Ag is actively ferried by cells into
the draining LN and does not enter by passive diffusion through
the lymphatics (Iezzi et al., 2006; Itano et al., 2003). Although the
soluble vaccine Ag EaRFP primed TEa cells sooner, yeast partic-
ulate Ag induced 3-fold more expansion of TEa cells at the peak
of T cell priming. Our findings also show that the system here of
TEa cells and EamCherry yeast should let us investigate and
identify the DC subsets that prime naive T cells in response to
fungal vaccination.
DC Subsets from Vaccinated Mice Prime Naive T Cells
Ex Vivo
Because we identified three subsets of CD11b+CD11c+ DCs
(skin-derived DCs, LN-resident DCs, and monocyte-derived
DCs) associated with vaccine yeast in the LN, we determinedost & Microbe 7, 474–487, June 17, 2010 ª2010 Elsevier Inc. 479
Figure 4. Surface Display of Vaccine Yeast-Derived Peptide by APCs in the Draining LNs
(A) Utility of EamCherry vaccine yeast and YAe mAb for detecting Ea:MHCII complexes on APCs. BMDCs (5 3 105 cells) were cocultured in vitro with 10 mM
SINFEKEL peptide, 5 mg/ml OVA, 53 105 TR20 yeast, 10 mMEa peptide, 5 mg/ml EaRFP, and 53 105 EamCherry yeast (from left to right). Yeast were cocultured
with DCs for 16 hr before nonadherent yeast were removed.Wells were harvested 1–4 days after coculture for analysis of Ea:MHCII display detected by YAemAb.
(B) Detection of Ea:MHCII complexes on LN cells loaded in vivo.Mice were vaccinated once s.c. with 200 mg EaRFP or with 107 PKH26+ TR20 yeast or EamCherry
yeast. Cells from the draining LNs were analyzed with YAe mAb for Ea:MHCII display by FACS.
(C) PKH26+ CD11b+ cells from the LNs of vaccinated mice were gated on to analyze Ea:MHCII display by staining with YAe mAb.
(D) Ea-Ag display in vivo by cells in the LNs of vaccinated mice. Ea:MHCII display is depicted by overlaying YAe+ CD11b+ cells (yellow), PKH26+ cells (red), and
total LN cells (blue). Mice received 200 mg soluble EaRFP or 107 PKH26+ TR20 yeast or EamCherry yeast, and LNswere harvested 3 days later. Cells were stained
with 50–100 mg YAe mAb. Numbers indicate percent of YAe+ cells in the gate for each population (as in Figures 1 and 2). Results are representative of three sepa-
rate experiments, each with three or four mice/group.
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Figure 5. Naive TEa Cells Report Fungal Ag Presentation In Vivo by Responding to Ea:MHCII
(A) TEa T cells report yeast Ea-Ag presentation ex vivo by cells from the draining LNs of immunized mice. CD11b+ cells (105) from naive mice or those vaccinated
with soluble EaRFP, TR20 (control) yeast, or EamCherry yeast were harvested 3 days after vaccination and cultured ex vivo with 53 105 naive CD4+ TEa T cells.
After 3 days of coculture, TEa cells were stained for activation markers. Data are representative of three independent experiments with three or four mice/group.
(B) Naive TEa cells report vaccine yeast Ea-Ag presentation in vivo. Thy1.1 TEa T cells were labeled with CFSE and transferred into C57BL/6 mice (105 cells/
mouse) vaccinated with 106 TR20 control or EamCherry yeast. Draining LNs were collected 4 days later, stained for activation markers, and analyzed by
FACS. T cells were gated on Thy1.1+ TEa cells. Numbers are percent of cells in the gate. Data are representative of three experiments with four mice/group.
(C) Fold expansion (numbers) of TEa cells was quantified for the experiment in (B). *p < 0.05 versus TR20 or naive mice. Error bars are the mean ±SD of three
experiments, each with four mice per group.
(D) The dynamics of vaccine Ea presentation to T cells in vivo. Thy1.1 TEa cells were labeled with CFSE and transferred intomice. After transfer, mice received 106
TR20 control (square) or EamCherry yeast (circle) s.c. Draining LNs were analyzed serially to assay proliferation (CFSElo) of Thy1.1+ TEa cells. The data are the
mean ±SD of three independent experiments with five mice/group at each time point.
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Figure 6. The Identity of APCs that Prime T Cells in Response to Fungal Vaccine
(A) Draining LN cells were sorted by FACS to identify DC subsets that prime naive TEa T cells ex vivo after immunization. Three days after vaccination with 100 mg
EaRFP or with 107 heat-killed TR20 control yeast or EamCherry yeast, LN cells were harvested from two or three mice/group. Gates were based upon FSC and
SSC, then FSC-W for singlet cells, and finally on B220 cells. CD11b+ cells were divided into four populations for sorting.
(B) Sorted populations were cultured (2 3 104 cells) ex vivo with bead-enriched CD4+ naive TEa cells (3 3 105) for 72 hr, and the cultures were harvested and
stained for T cell activation markers. Roman numerals and names correspond to sorted populations in (A). Numbers in gates are the percent of TEa cells with
the activation marker. Results are representative of three independent experiments pooling LNs of two mice/group.
(C) Skin-derived DCs sorted from the LNs of vaccinated mice. DEC205 (left panel) was used to sort skin-derived DCs, and Ly6C (right panel) to collect cells as
a ‘‘negative’’ control for culture ex vivo with TEa cells in (D). Numbers reflect percent of cells in the gate.
(D) Sorted DEC205+ cells and control Ly6C+ cells (as in C) from vaccinatedmice were cultured (23 104) ex vivo with bead-enriched naive TEa cells (33 105). After
72 hr, T cells were stained for activation and analyzed by FACS. Results are representative of two independent experiments with two mice/group.
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priming protective T cells in this model of immunization against
fungi. Based on the kinetics of T cell priming in vivo, which
showed initial T cell expansion at 72 hr in response to EamCherry
yeast (Figures 5C and 5D), we collected and functionally
analyzed in vivo loaded APCs from the draining LNs 3 days after
vaccination. The cells were sorted by FACS according to gates
that correspond to the different DC subsets (Figure 6A). Four
populations were sorted from total LN cells: resident DCs
(population I), monocyte-derived inflammatory DCs (II), mono-
cytes/macrophages (III) (as a negative control), and skin-derived
dermal and Langerhans DCs (IV) (Figure 6A). Populations from
mice vaccinated with soluble EaRFP, EamCherry yeast, or
TR20 control yeast were sorted in parallel. TEa cells were
cocultured with sorted cells ex vivo for 72 hr and analyzed
for the expression of activation markers. In the EamCherry
yeast vaccine group, LN-resident DCs activated the TEa cells,
as defined by their increased expression of surface CD44
and CD69 when compared to the TR20 control group; no other482 Cell Host & Microbe 7, 474–487, June 17, 2010 ª2010 Elsevier Insorted populations from the EamCherry group activated the
TEa cells (Figure 6B). In the soluble EaRFP group, skin DCs acti-
vated the TEa cells as described (Itano et al., 2003), although
monocyte-derived DCs and LN-resident DCs were also capable
of activating the cells in this ex vivo assay.
We were surprised that skin DCs (population IV in Figure 6A)
did not prime TEa cells in EamCherry-vaccinated mice, since
the fungal vaccine is most effective when injected s.c. (Wu¨thrich
et al., 2000). One possibility is that skin DCswere diluted by other
cell types, since population IV is sorted from total LN cells. We
observed in Figure 1C that populations IV and V are heteroge-
neous, and only a minor proportion of them are DEC205+ skin
DCs (20% of the PKH26+ population). This raised the possi-
bility that the lack of T cell activation with this population was
due to a nonoptimal ratio of DCs to TEa cells in vitro. To address
this, we sorted DEC205+ cells in vaccinated mice to enrich skin
DCs (Figure 6C), and in parallel, we sorted Ly6C+ monocytes
as a control, which did not prime TEa cells in the EamCherry
group (Figure 6B). We obtained 10-fold fewer cells by sortingc.
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suggesting that skin DCs were indeed ‘‘diluted out’’ by other
LN cells in the original gating strategy. DEC205+ cells loaded
in vivo with EamCherry yeast activated TEa cells following cocul-
ture. Over 20% of TEa cells expressed surface CD69 in this
vaccine group, compared to 3% of cells in the TR20 control
group. DEC205+ skin DCs loaded in vivo with soluble EaRFP
also primed naive TEa cells, as expected (Itano et al., 2003).
Thus, skin-derived DCs from mice vaccinated with yeast can
also prime naive T cells ex vivo. The Ly6C+-sorted cells con-
tained 5-fold more cells than population II because the sorted
cells are composed of multiple monocyte-derived populations,
including monocytes, monocyte-derived DCs, and macro-
phages. However, the Ly6C+ cells from each vaccine group
failed to prime TEa cells.Analysis of T Cell Priming In Vivo Unveils Collaborative,
Indispensable Roles of DC Subsets
Ex vivo assays do not necessarily portray the functional behavior
of APCs in vivo, where distinct DC subsets may collaborate to
prime naive T cells (Allenspach et al., 2008). Hence, we studied
the in vivo role of distinct DC subsets in priming naive T cells in
response to vaccination. We utilized CCR2/, CCR7/, and
CD11cDTR mice (Figures 7A–7C). We adoptively transferred
naive TEa cells into these mice and monitored T cell activation
after vaccination with EamCherry or TR20 control yeast. Our
sort data above revealed that LN-resident DCs and skin DCs
loaded with Ag in vivo can prime naive T cells ex vivo (Figure 6).
The role of these DC subsets in in vivo priming was confirmed in
CCR7/ and CD11cDTR mice (Figures 7A and 7C). CCR7/
mice, in whichmigration of skin DCs is impaired, showed sharply
reduced priming of naive TEa cells despite our earlier finding that
skin DCs were a minor (<20%) yeast-associated population in
the draining LNs (Figure 1B). Nearly 69% of naive TEa cells
were CFSElo and primed in wild-type mice vaccinated with Eam-
Cherry yeast, whereas 22% of the cells were primed in CCR7/
mice (Figure 7A). Impairment in TEa priming was even more
striking in CD11cDTRmice, which lack conventional LN-resident
DCs and where the absence of CD11chi cells virtually abrogated
TEa cell proliferation (Figure 7A).
Similarly, the priming of TEa cells was partially impaired in
CCR2/ mice; proliferation of TEa cells in these mice reached
28% of the maximal response, as compared to 46% in
wild-type mice (Figure 7B). Hence, although monocyte-derived
inflammatory DCs are the least efficient subset in displaying
Ea:MHCII after Ag loading in vivo, and our ex vivo analysis of
sorted monocyte-derived inflammatory DCs demonstrated that
they are incapable of priming TEa cells in vitro, these DCs have
a requisite role in the priming of antifungal T cells in vivo in
response to vaccination. This is perhaps not surprising, because
monocyte-derived DCs are the first to infiltrate the LNs with
vaccine yeast after immunization, and this population contains
the majority of Ag-loaded cells (Figure 1B). Thus, while ex vivo
analysis pointed to the functional role of two of the three DC
subsets—skin DCs and LN DCs, but not monocyte-derived
DCs—in priming TEa cells, in vivo studies establish that the
various DC subsets mediate distinct, collaborative, and indis-
pensable roles in priming T cells in response to vaccine.Cell HDISCUSSION
We provide here a comprehensive picture of the earliest stages
in the generation of vaccine immunity to a systemic fungal infec-
tion. Because DCs are essential in understanding how vaccine
immunity is generated (Steinman, 2008), we focused on eluci-
dating their role in our model. We found that multiple DC subsets
collaborate to prime naive Ag-specific CD4 T cells and that the
different subsets mediate distinct functions. Monocyte-derived
inflammatory DCs mainly transport vaccine yeast Ag into the
LN, whereas LN-resident DCs and, to a lesser extent, migrating
skin DCs directly prime naive T cells. Our work reveals an intri-
cate interplay between DC subsets during the generation of
vaccine immunity to fungi.
Monocyte-derived inflammatory DCs are the earliest and
largest cell population that associates with vaccine yeast in the
LN.We identifiedmonocyte-derivedDCsby their Ly6Chi CD11cint
phenotype (Leo´n and Ardavı´n, 2008; Nakano et al., 2009). These
cells were not detected in naive mice, and their numbers
increased sharply after vaccination, supporting their character-
ization as inflammatory cells. In CCR2/mice, their recruitment
into the draining LN was curtailed, and the delivery of vaccine
yeastwasalso reduced.While theseDCsplayedakey role inearly
recognition, uptake, and trafficking of yeast into the LN, they did
not efficiently process and present Ag or prime naive T cells. For
such analyses, we exploited the TEa system. Vaccine yeast
expressing EaRFP were used to track yeast-derived Ea:MHCII
complexes on APCs with YAe mAb and monitor priming of naive
Ea-specific ‘‘antifungal’’ TEa cells. Monocyte-derived DCs had
little processed Ea on their surfaces. In vaccinated mice, these
cells were unable to prime naive TEa cells ex vivo.
This discrete role of monocyte-derived DCs in trafficking
vaccine yeast to the draining node contrasts with their broader
functions in other eukaryotic models. In a L. major cutaneous
infection model, Leo´n et al. (Leo´n et al., 2007) detected two
monocyte-derived inflammatory DC populations: LN mono-
cyte-derived DCs (LN mo-DCs) are an immature Ly6Chi popula-
tion and dermal monocyte-derived DCs (dermal mo-DCs) are
a more mature Ly6int population. The dermal mo-DCs were
found to be the principal population expressing L. major LACK
Ag peptide and activating Ag-specific T cells ex vivo.
In our system, the inflammatory DC is phenotypically most
similar to LN mo-DCs (Ly6Chi CD11bhi CD11cint MHCIIlo)
described by Leo´n et al. (Leo´n et al., 2007). Those cells are
purportedly monocytes that enter the LN directly from the blood
and differentiate into DCs. There, DCs would be located along
high endothelial venules and sample soluble Ags that enter via
the lymph. The monocyte-derived inflammatory DCs in our
model must be different. They are the first cells to associate
with yeast in the LN (24 hr after vaccination). However, these
monocyte-derived DCs don’t acquire PKH26+ yeast Ag via the
lymph. Soluble Ag typically enters the node by 30min after injec-
tion into the skin; DCs that ferry Ag enter later, by around 14 hr
after injection (Iezzi et al., 2006; Itano et al., 2003). In mice vacci-
nated with yeast, we first detected PKH+ signal in the node at
24 hr; therefore, it was likely ferried by DCs. After fungal vaccine,
proliferation of naive Ea-specific TEa cells in vivo was delayed
until 72 hr, also consistent with cell transport of Ag into the
node. Third, impaired monocyte migration in CCR2/ miceost & Microbe 7, 474–487, June 17, 2010 ª2010 Elsevier Inc. 483
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LN, demonstrating that these monocyte-derived DCs transport
yeast into the node from the site of vaccination rather than
sampling soluble, cell-free Ag that arrives via the lymph.
The other subset of monocyte-derived inflammatory DCs in
the L. major model were dermal mo-DCs (Ly6Clo, CD11bint,
CD11cint MHCIIhi) (Leo´n et al., 2007). Neither does our inflamma-
tory DCmatch that phenotype. Our cells may be an early pheno-
type of the dermal mo-DCs, since that subset was described at
4 weeks after infection with L. major. Our model instead focused
on the initial stages of vaccination at 3 days postinjection. Thus,
yeast-associated monocyte-derived DCs are neither dermal
mo-DC nor LN mo-DCs reported by Leo´n et al. (Leo´n et al.,
2007), but likely another monocyte population that arrives at
the skin, quickly picks up vaccine yeast, differentiates into
CD11b+ DCs, and transports Ag into the LN. Differences
between the two studies may be due to the differences in timing
of analysis or burden of Ag at those points during infection and
especially the differing nature of these eukaryotic pathogens.
The Ly6Chi monocyte-derived DC subset in our model is
similar in phenotype and kinetics to inflammatory monocyte-
derived CD11b+ DCs in models of pulmonary aspergillosis
(Hohl et al., 2009) and cryptococcosis (Osterholzer et al.,
2009). Hohl et al. reported that Ly6Chi CD11b+ CD11c+ DCs
harbored conidia in the lung 2 days postinfection. These DCs
required CCR2 for recruitment into the lung and draining LNs
where they induced Th1 differentiation of naive Aspergillus-
specific Tg T cells. We also saw that loss of CCR2 delayed the
delivery of vaccine yeast into the draining LNs and reduced the
number of APCs associated with yeast. In contrast, however,
we found that loss of CCR2 only partially impaired priming of
naive Ag-specific T cells. The Aspergillus work did not address
how monocyte-derived DCs contribute to lung T cell priming,
that is, whether the DCs solely transported Ag to the node,
primed T cells, or both. Nevertheless, the precise function(s) of
monocyte-derived DCs were shown to differ with the tissue
site. DCs were essential in priming T cells in the lung, but
dispensable for systemic priming in the spleen.
By using YAe antibody to detect Ag display, we went beyond
the detection of cell Ag load by PKH26 signal and monitored the
ability of distinct DC subsets to display yeast-derived peptide on
their surfaces. Importantly, resident DCs displayedmore surface
peptide than migratory DC subsets. In CCR2/ and CCR7/
mice, however, PKH26+ signal and surface peptide display
were reduced in resident DCs, suggesting that yeast Ag is
transferred from migratory DCs (skin- or monocyte-derived) to
resident DCs. YAe staining also revealed that different DC
subsets presented soluble protein (EaRFP) versus live yeast.
Whereas Ag display after soluble EaRFP injection was seen in
the skin-derived DC subsets, vaccine yeast triggered greaterFigure 7. Impairments in Vaccine Priming of T Cells after the Loss of D
(A–C) In vivo priming of Ag-specific T cells. CCR7/ (A), CCR2/ (B), and CD11c
DCs, monocyte-derived DCs, and LN-resident DCs, respectively. Naive Thy1.1+ T
a day before vaccination with TR20 control yeast or EamCherry yeast (107). Drainin
cells (TEa cells) were gated (upper row) and analyzed for proliferation in vivo. Perc
(third row). Numbers and fold expansion of Thy1.1+ TEa cells is shown on the right
versus transgenic strain; **p < 0.05 for EamCherry versus TR20. The results are
bars are the mean ±SD. The results were similar when LNs were harvested 48 h
Cell Hdisplay of processed Ag in the LN-resident DCs. Althoughmono-
cyte-derived DCs contained the largest burden of PKH+ yeast,
they displayed the fewest Ea:MHCII complexes. Thus, engulfing
many yeast may have impaired Ag presentation in these cells. In
a herpes simplex virus 1 (HSV-1) model, the large viral Ag load
impaired DC function and was associated with defective cell
trafficking (Eidsmo et al., 2009).
Based on YAe staining and Ag display, we postulated that
mainly skin DCs, after soluble EaRFP vaccination, and LN-
resident DCs, after vaccine yeast administration, would prime
naive T cells. Our ex vivo T cell assayswith sorted cells confirmed
the YAe staining results and established that in vivo loaded LN-
resident DCs and, to a lesser extent, migratory skin-derived
DCs primed naive T cells. However, previous studies in an
OVA-OT II system showed that migratory and LN-resident DCs
could prime T cells ex vivo independently of each other, but
in vivo priming required the cooperation of both subsets (Allens-
pach et al., 2008). In keeping with that study, we observed
reduced priming of naive T cells inCD11cDTRmice (lack LN-resi-
dent DCs [CD11chi cells]) (Bennett and Clausen, 2007) and
CCR7/ mice (impaired entry into the LN of migratory DCs)
(Jang et al., 2006; Ohl et al., 2004). In CD11cDTR mice, T cells
were not primed in vivo; in CCR7/ mice, T cell priming was
reduced 3-fold. Any residual response in CCR7/mice might
be due to monocyte-derived DCs that compensated for skin
(likely dermal) DCs as the migratory subset. Although mono-
cyte-derived DCs are not efficient in priming T cells directly,
they likely transfer Ag from the skin to LN-resident cells, thereby
preserving T cell priming in CCR7/mice. Our CCR7/ results
contrast with those in CCR2/ mice, where the defect in T cell
priming was less pronounced. There, the putative role of
CCR2+ monocyte-derived DCs likely could be rescued partially
by other populations in the skin, likely the dermal DCs. This
finding reinforces the conclusion by Hohl et al. (Hohl et al.,
2009) that tissue site influences the role of monocyte-derived
DCs in response to fungi. Our study offers new insight into how
these DCs help prime T cells to yeast injected into the skin and
promote vaccine immunity to fungi.
LN-resident DCs were indispensable in the generation of
vaccine immunity to fungi in our model. This DC subset made
up the bulk of surface Ag-displaying cells in the draining LNs of
vaccinated mice, and they primed naive TEa T cells ex vivo
and were required in priming them in vivo. LN-resident DCs
also have a seminal role in inducing T cell immunity against
Leishmania and HSV-1 (Allan et al., 2006; Iezzi et al., 2006). In
HSV-1 infection, the route of inoculation determines which DC
subset induces the activation of T cells (Lee et al., 2009). Dermal
DCs prime T cells when HSV is introduced via the mucosa,
whereas LN-resident DCs show amore prominent role after nee-
dle inoculation (Lee et al., 2009). One explanation for theC Populations
DTR (C) mice were used to analyze T cell priming in the absence of skin-derived
Ea T cells (23 105) were labeled with CFSE and transferred s.c. into recipients
g LNswere harvested 3 days after vaccination and analyzed by FACS. Thy1.1+
ent of cells proliferating is displayed within each gate (second row) or histogram
. Numbers are fold change versus TR20 control. *p < 0.05 for EamCherry in WT
representative of three independent experiments with three mice/group. Error
r after vaccination (Figure S6).
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the LN-resident DCs in skin-draining LNs are available to induce
protective immunity. Conversely, tissue DCs at other routes or
sites of infection may not be as efficient in priming antifungal
T cells. This may explain the low efficacy of our fungal vaccine
given by the respiratory route (Wu¨thrich et al., 2000).
Most studies of the role of DCs in priming antimicrobial T cell
responses have emphasized the seminal role of a distinct DC
subset, according to the pathogen or the site of entry or injection.
In contrast, our study reveals the interplay among multiple
distinct subsets. Whereas both monocyte-derived and dermal
DCs ferry vaccine yeast into the draining LN, neither subset fully
compensates for the other in chemokine receptor-deficient
mice, and the priming of CD4 T cells was impaired in both
CCR2/ and CCR7/ mice. CCR7/ mice showed a striking
defect in T cell priming, likely due to the multiple functions of
dermal DCs: trafficking and transferring of Ag to resident DCs,
as well as priming of T cells. We did not formally showAg transfer
to resident DCs, but the findings that Ag must be ferried into the
node by cell migrants and that blocking cell migration by toxin
24 hr after vaccination failed to curtail the uptake of Ag in resident
DCs are most consistent with that mechanism.
Our study exploited a model Ag to clarify sequential steps in
initiating Ag-specific antifungal immunity, but it is valid to ask
whether the response to this model Ag accurately portrays
vaccine immunity to fungi. We recently used CD4 T cells from
a newly created Blastomyces-specific TCR Tg mouse, which
confirmed our results here with TEa cells (our unpublished
data). Overall, our results typify the cooperation of multiple DC
subsets needed to prime CD4 T cells in response to the model
Ag OVA (Allenspach et al., 2008). Upon s.c. injection of live
attenuated yeast, the generation of vaccine immunity likewise
demands the dynamic and functional collaboration of both
migratory and resident DC subsets.
EXPERIMENTAL PROCEDURES
Mice
Wild-type C57BL/6 mice were obtained from the National Cancer Institute
(Bethesda, MD). TEa TCR transgenic mice were provided by A.Y. Rudensky
at the Howard Hughes Medical Institute, University of Washington (Itano
et al., 2003). CCR2/ (stock #04999), CCR7/ (stock #05794), and
CD11cDTR/GFP mice (stock #04509) were obtained from Jackson Labora-
tory. CD11chi cells were depleted from CD11cDTR/GFP mice by one intraper-
itoneal injection of 100 ng diphtheria toxin per animal. Mice were 10–12 weeks
of age at the time of our experiments. Experimental procedures and housing
were performed according to the guidelines of the University of Wisconsin
Animal Care Committee, who approved this work.
Fungi
Blastomyces strain 55 is an attenuated yeast created from the isogenic virulent
strain American Type Culture Collection (ATCC) 26199 (Manassas, VA) by
targeting and deleting the gene encoding BAD1 (Brandhorst et al., 1999). Eam-
Cherry yeast was engineered as described in Supplemental Experimental
Procedures. Strain TR20 served as a control in some experiments. All fungal
isolates were maintained in the yeast form at 39C on Middlebrook 7H10
agar slants (BD Diagnostics; Franklin Lakes, NJ).
Staining of Vaccine Yeast and Subcutaneous Immunization
Yeast were labeled with the red fluorescent linker PKH26GL (Sigma, St. Louis)
in Diluent C (Sigma) at a concentration of 2 3 106 yeast/ml PKH26 for 5 min at
room temperature. An equal volume of FBS (Cellgro; Mediatech, Inc.; Mana-486 Cell Host & Microbe 7, 474–487, June 17, 2010 ª2010 Elsevier Inssas, VA) was added to bind excess PKH26 for 1 min, followed by a single
wash with RPMI medium supplemented with 10% FBS and then by two
washes with PBS. Yeast were labeled with CFSE using the manufacturer’s
instructions (Molecular Probes; Eugene, OR) for lymphocytes and yielded
strong fluorescent intensity. For vaccination, PKH-labeled yeast were sus-
pended at 1 3 107 cells/ml in PBS, and two injections were given s.c. Each
injection site received 5 3 106 yeast in 500 ml. Approximately 100–200 mg
EaRFP in PBS was administered s.c. as for vaccine yeast. The EaRFP (Ea
plus DsRed) protein was expressed in recombinant form in Escherichia coli
and purified as described by Itano et al. (2003). DC migration into the draining
LN was blocked by adding 500 ng pertussis toxin (Sigma-Aldrich, St. Louis) to
vaccine yeast during s.c. injection. To inhibit DC migration following vaccina-
tion, 300 ng pertussis toxin was given intravenously (i.v.) 24 hr after vaccine
yeast were injected.
T Cell Preparation and Adoptive Transfers
Naive CD4+ T cells were harvested from the spleen and LNs of naive TEamice.
Splenocytes and LN single-cell suspensions were enriched on CD4 magnetic
beads (IMag, BD Bioscience). T cells were enriched per the manufacturer’s
instructions. T cells were cocultured with various concentrations of DCs at
3 3 105 T cells/well. For adoptive transfers, single-cell suspensions of whole
splenocytes of naive TEa Thy1.1+ mice were stained with CFSE (Molecular
Probes) before transfer, per the manufacturer’s instructions. CFSE-labeled
TEa cells were transferred i.v. at 106 or 2 3 106 per animal to obtain
from 105 to 2 3 105 CD4+ T cells, respectively, since 10% of total spleno-
cytes are CD4+ TEa T cells. A day after transfer, mice were vaccinated with
106 yeast s.c., and brachial and inguinal LNs were harvested 3 days later.
FACS Analysis and Cell Sorting
These were performed as described in Supplemental Experimental
Procedures.
Statistics
Differences in the number of cells were analyzed using Wilcoxon rank test for
nonparametric data or a t test if data were normally distributed. A Bonferroni
adjustment was used to correct for multiple tests. A value of p < 0.05 is consid-
ered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
Supplemental References, and six figures and can be found with this article
online at doi:10.1016/j.chom.2010.05.010.
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